---
title: 'Long-term safety and effectiveness of canakinumab in patients with monogenic
  autoinflammatory diseases: results from the interim analysis of the RELIANCE registry'
date: '2024-02-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38360038/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240216170700&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSION: Data from this analysis confirm the long-term safety and
  effectiveness of canakinumab for the treatment of CAPS, FMF, TRAPS and ...'
disable_comments: true
---
CONCLUSION: Data from this analysis confirm the long-term safety and effectiveness of canakinumab for the treatment of CAPS, FMF, TRAPS and ...